About the Journal

Journal Name: The Cancer Research Review

Online ISSN: 3006-9343

Print ISSN: 3006-9335


"The Cancer Research Review" is a peer-reviewed journal dedicated to publishing high-quality research in all areas of cancer biology, oncology, and related fields. It serves as a platform for researchers, clinicians, and scientists to share their latest findings, advancements, and insights aimed at understanding and combating cancer.


The journal covers a wide range of topics within the realm of cancer research, including but not limited to:

  1. Cancer biology: Understanding the molecular mechanisms underlying cancer initiation, progression, and metastasis.
  2. Oncogenomics and molecular profiling: Studying the genetic and epigenetic alterations associated with different cancer types to identify potential therapeutic targets.
  3. Cancer immunology and immunotherapy: Investigating the role of the immune system in cancer development and exploring novel immunotherapeutic approaches.
  4. Cancer diagnostics and imaging: Developing new techniques and technologies for early detection, accurate diagnosis, and monitoring of cancer.
  5. Cancer treatment strategies: Evaluating the efficacy and safety of various treatment modalities such as chemotherapy, radiation therapy, targeted therapy, and emerging therapies like gene therapy and CAR-T cell therapy.
  6. Precision medicine and personalized oncology: Tailoring cancer treatment strategies based on individual patient characteristics, including genetic makeup, tumor biology, and other factors.
  7. Cancer survivorship and supportive care: Addressing the long-term effects of cancer and its treatment, as well as improving the quality of life for cancer survivors through supportive care measures.
  8. Cancer epidemiology and prevention: Identifying risk factors, trends, and patterns of cancer incidence and mortality, as well as developing strategies for cancer prevention and early intervention.

Publication Format:

"The Cancer Research Review" publishes original research articles, reviews, perspectives, commentaries, and editorials contributed by leading experts and researchers in the field. All submissions undergo rigorous peer review to ensure scientific rigor, accuracy, and relevance. The journal follows a digital-first publishing model, providing immediate online access to accepted articles for global dissemination and accessibility.


The primary audience of "The Cancer Research Review" includes researchers, clinicians, oncologists, pharmacologists, geneticists, immunologists, radiologists, epidemiologists, and other professionals involved in cancer research, diagnosis, treatment, and patient care. Additionally, the journal aims to engage policymakers, healthcare practitioners, cancer advocacy organizations, and the broader scientific community interested in advancing cancer research and improving patient outcomes.